Expression of protease IV by Pseudomonas aeruginosa during ocular infections contributes significantly to tissue damage. However, several P. aeruginosa strains isolated from ocular infections or inflammatory events produce very low levels of protease IV. The aim of the present study was to characterize, genetically and phenotypically, the presence and expression of the protease IV gene in a group of clinical isolates that cause adverse ocular events of varying degrees, and to elucidate the possible control mechanisms of expression associated with this virulence factor. Protease IV gene sequences from seven clinical isolates of P. aeruginosa were determined and compared to P. aeruginosa strains PAO1 and PA103-29. Production and enzyme activity of protease IV were measured in test strains and compared to that of quorumsensing gene (lasRI) mutants and the expression of other virulence factors. Protease IV gene sequence similarities between the isolates were 97.5-99.5 %. The strains were classified into two distinct phylogenetic groups that correlated with the presence of exo-enzymes from type three secretion systems (TTSS). Protease IV concentrations produced by PAODlasRI mutants and the two clinical isolates with a lasRI gene deficiency were restored to levels comparable to strain PAO1 following complementation of the quorum-sensing gene deficiencies. The protease IV gene is highly conserved in P. aeruginosa clinical isolates that cause a range of adverse ocular events. Observed variations within the gene sequence appear to correlate with presence of specific TTSS genes. Protease IV expression was shown to be regulated by the Las quorum-sensing system.
INTRODUCTION
Inflammation and infection in the cornea (keratitis) arising from Pseudomonas aeruginosa infection can lead rapidly to scarring and loss of sight unless prompt and targeted treatment is initiated (Sankaridurg et al., 2000) . P. aeruginosa virulence is attributed, in part, to the production of several destructive proteins and stimulation of host immune response in the ocular tissues (Hazlett, 2002) . The virulence factors most commonly associated with P. aeruginosa-induced ocular damage are exo-enzymes S (exoS) and U (exoU) (Fleiszig et al., 1997) , elastase (lasB) (Kessler & Blumberg, 1987) , alkaline protease (aprA) (Twining et al., 1993) and protease IV (piv) (O'Callaghan et al., 1996) . Another protease, P. aeruginosa small protease (PASP), can also cause rapid corneal damage (Marquart et al., 2005) . Other important pathogenic mechanisms include the genes involved in translocation and activation of virulence proteins via the type II (xcp) and type III secretory pathways (Sandkvist, 2001; Yahr et al., 1997) .
Protease IV is a lysine-specific endoprotease and a significant virulence factor for pathogenesis of P. aeruginosa in the eye and lung (Caballero et al., 2004; Engel et al., 1997; Wilderman et al., 2001) . Mature protease IV degrades important host immunological proteins such as complement and IgG (Engel et al., 1998) . Protease IV also compromises the integrity of structural proteins such as elastin (Wilderman et al., 2001) , causing tissue damage and facilitating bacterial infection. Protease IV degrades the iron-binding proteins lactoferrin and transferrin (Wilderman et al., 2001) enabling P. aeruginosa to scavenge iron from the host via the siderophore, pyoverdine. Pyoverdine has a high affinity for iron and sequesters it from the surrounding environment, facilitating iron uptake by the bacterium (Ochsner et al., 1995) . Moreover, pyoverdine has been shown to act as a signal molecule for the synthesis of protease IV (Wilderman et al., 2001 ).
Controlled expression of several key P. aeruginosa virulence factors, including elastase (lasB) (Pearson et al., 1997) , exotoxin A , type II secretory pathway proteins (xcp) (Chapon-Hervé et al., 1997) and pyoverdine (Kim et al., 2005; Stintzi et al., 1998) are mediated by population density bio-sensor mechanisms, a process known as quorum sensing. P. aeruginosa has two quorum-sensing systems, the Las and Rhl systems, each influencing the expression of a range of virulence factors (Passador et al., 1993; Pearson et al., 1994) . The systems are organized in a hierarchical manner such that the Rhl system is partially controlled by Las activation (Latifi et al., 1996) . The Las and Rhl quorum-sensing molecules are acylhomoserine lactones (AHL). Once the bacterial population reaches an appropriate size, activation of the quorum-sensing-controlled virulence genes is initiated.
Protease IV has been reported as a key virulence factor in the pathogenesis of P. aeruginosa in the eye (Engel et al., 1997) . However, a number of 'low protease'-producing strains of P. aeruginosa have been isolated from microbial keratitis and corneal inflammation events (Zhu et al., 2002 (Zhu et al., , 2004 ). In the current study, the protease IV gene sequence was determined for clinical isolates causing a range of adverse ocular events. Sequence similarities were correlated with the presence or absence of exo-enzymes of the type three secretion system (TTSS). The presence and activity of protease IV was determined for each of the low-proteaseproducing isolates and regulation of protease IV production by the Las quorum-sensing system was demonstrated.
METHODS
Bacterial strains, plasmids, and growth conditions. The six strains of P. aeruginosa used in this study (Table 1) were isolated from the eyes or contact-lens storage cases of subjects during asymptomatic routine contact-lens wear or following corneal infection or inflammation events. P. aeruginosa PAO1 was included as a reference strain. The isogenic quorum-sensing mutant of strain PAO1 (PAO1DlasRI : : Gm) and the P. aeruginosa shuttle vector pUCPSK were kindly supplied by Dr Scott Beatson (Institute for Molecular Bioscience, University of Queensland, Australia). Escherichia coli strain DH5a, from our laboratory collection, was used during the construction of the lasRI plasmid. Bacteria were stored at 280 uC in tryptic soy broth (TSB, Oxoid) containing 30 % (v/v) glycerol and were cultured at 37 uC on tryptic soy agar (TSA, Oxoid). For general laboratory work, colonies of P. aeruginosa were inoculated into 5 ml TSB and incubated at 37 uC with vigorous shaking for 18 h to stationary phase, achieving an OD 660 of 2.0. Bacterial cells were recovered by centrifugation at 16 000 g at 4 uC for 10 min and the supernatant was passed through a 0.22 mm filter to remove any remaining cells. For growth of bacteria containing vector DNA, media were prepared as above with the following antibiotics as required: 100 mg ampicillin ml 21 for E. coli and 400 mg carbenicillin ml 21 and/ or 100 mg gentamicin ml 21 for P. aeruginosa. For genetic transformation experiments, E. coli cells were rendered chemically competent. An overnight cell culture was grown as above, washed once in sterile PBS (pH 7.4) and resuspended in ice-cold 0.15 M MgCl 2 for 30 min (Mercer & Loutit, 1979) . For P. aeruginosa cell competency, the same process was employed but with the cultures grown overnight at 43 uC (Holloway, 1965) .
PCR amplification of the protease IV gene. PCRs were performed to amplify the entire protease IV gene and promoter region. Based on the published sequence of strain PAO1 (http://www.pseudomonas. com), novel primers were designed using the GCG software within BioManager (http://biomanager.info/) to produce an amplicon of 1876 bp, identical to non-coding regions surrounding the piv gene. Primers were synthesized by Invitrogen. The primer sequences were as follows: PIVflk-for, 59-AGAGCCACTCCAGACCAAAC-39; PIVflkrev, 59-GGATAAACGGCGGATAACAC-39.
Genomic DNA for each PCR was prepared by incubating 1 ml fresh overnight bacterial broth culture with 19 ml microLYSIS buffer (Microzone) and heating in a thermal cycler (Corbett) using the following conditions: 65 uC for 5 min, 96 uC for 2 min, 65 uC for 4 min, 96 uC for 1 min, 65 uC for 1 min, 96 uC for 30 s and then cooled to 25 uC.
PCR amplification was performed using 3 units of the high-fidelity proofreading polymerase Pfu (Promega) in a 50 ml reaction containing buffer (20 mM Tris/HCl, pH 8.8; 10 mM KCl; 10 mM (NH 4 ) 2 SO 4 ; 2 mM MgSO 4 ; 0.1 % Triton X-100 and 0.1 mg BSA ml 21 ), 200 mM each dNTP (Promega), 0.2 mM each primer and 2 ml template DNA/microLYSIS mixture. Reactions were performed for an initial denaturation period of 95 uC for 7 min followed by 30 cycles of 95 uC for 30 s, 60 uC for 30 s and 72 uC for 90 s, and a final extension step at 72 uC for 10 min. PCR products were separated by electrophoresis through a 1.5 % agarose gel in TBE buffer (45 mM Tris, pH 8.0; 45 mM boric acid; 1 mM ethylenediaminetetracetic acid), stained with SybrSafe (Invitrogen) and visualized under UV illumination.
Protease IV gene sequencing. Amplicons from each ocular strain were purified using Wizard SV Gel and PCR Clean Up System kits (Promega), blunt-end cloned into pCR4-TOPO according to the manufacturer's instructions and sequenced using a nested deletion method on the ABI Prism 3700 Automated DNA platform (Supamac). The nested deletion sequences for each clone were compiled and aligned using BioEdit version 7.0.5 (http://jwbrown. mbio.ncsu.edu/BioEdit/bioedit.html; Hall, 1999) to produce a consensus sequence for each strain. Each new consensus sequence was made available in the NCBI GenBank database, under accession numbers DQ351518-DQ351524. Each sequence was aligned with the published gene sequence of strains PAO1 (Stover et al., 2000) and PA103-29 (Caballero et al., 2004) using BioEdit. A phylogenetic tree was generated using fastDNAml (Olsen et al., 1994) software within the BioManager service.
Zymography analysis. Gelatin zymography techniques based on those of Twining et al. (1993) were employed to determine protease IV activity in the isolates. Cell-free culture supernatants were preincubated with or without the protease IV specific inhibitor N-a-rtosyl-L-lysine chloromethyl ketone (TLCK, Sigma-Aldrich) (Engel et al., 1998) . TLCK was prepared as a stock solution of 10 mM in 5 mM HCl. Aliquots of each supernatant were incubated for 30 min at 25 uC with 0.2 volumes of TLCK stock solution or 0.2 volumes of 5 mM HCl as a control. Treated supernatants were combined with SDS sample buffer (final concentration: 50 mM Tris/HCl, pH 6.8; 10 %, v/v, glycerol; 0.2 %, w/v, bromophenol blue; 0.5 %, w/v, SDS), and 15 ml of the mixture was loaded into a 7.5 % SDS-polyacrylamide gel containing 0.1 % gelatin (Type A from porcine skin, SigmaAldrich) with a 4 % stacker. A pre-stained molecular mass marker was included (Kaleidoscope Precision Plus, Bio-Rad). Electrophoresis was performed at 4 uC under non-reducing conditions and bands were resolved at 25 mA per gel until the 50 kDa pre-stained marker band was approximately 10 mm from the edge of the gel. To allow protein renaturation, SDS was removed by gentle agitation with 2.5 % Triton X-100 (Sigma-Aldrich) in distilled water for 1 h. Gels were rinsed twice in distilled water and incubated in development buffer (50 mM Tris/HCl, pH 8.0; 10 mM CaCl 2 ; 1 mM ZnCl 2 ; 150 mM NaCl) at 37 uC for 24 h. Gels were stained and destained simultaneously with 0.01 % Coomassie blue R-250 in glacial acetic/methanol/ distilled water (1 : 3 : 6) for 1 h, according to the method of Leber & Balkwill (1997) . Zymogram experiments were repeated twice, beginning from frozen bacterial stock cultures.
Chromogenic substrate assay. The activity of protease IV in cell-free culture supernatants was measured by the breakdown of the chromogenic substrate Chromozym PL (Roche) which reacts specifically with protease IV in P. aeruginosa culture supernatants (Caballero et al., 2004) . Briefly, 20 ml pre-treated sample (with or without TLCK as for zymography) and 40 mg of Chromozym PL were combined in reaction buffer (50 mM Tris/HCl, pH 8.0; 150 mM NaCl) to a total volume of 100 ml. A 405 was measured at 5 min intervals for a total of 3 h. Protease IV activity ml 21 in supernatant was calculated as follows: V/(v6E6d)6DA min 21 ; where V5total assay volume; v5sample volume; E5extinction coefficient (at 405 nm510.4); d5path length (100 ml volume in microtitre plate#0.53 cm); and DA min 21 5the maximum change in absorbance min
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. To determine maximal rate of change in absorbance, the data for each strain were first plotted as a function of time (data not shown). The protease activity was then normalized to account for variation in bacterial cell growth as observed at OD 660 ; total protease activity was divided by optical density to result in mM/OD 660 .
Samples were analysed in neat and ten-fold concentrated states. To concentrate supernatants, 500 ml each sample was applied to Amicon Ultrafree-MC 5 kDa molecular mass cut off centrifugal filters (Millipore) and centrifuged at 16 000 g at 20 uC until the volume of the retentate was reduced to 50 ml.
Protein immunoblot analysis. The presence of protease IV protein from P. aeruginosa isolates was examined using western blotting. Culture supernatants were analysed in neat or concentrated forms, as in the chromogenic substrate experiments, but were not pre-treated with TLCK. Volumes (30 ml) of each supernatant and a purified sample of protease IV (kindly supplied by Professor R. O'Callaghan and Dr B. Thibodeaux, Louisiana State University, USA), were prepared in NuPAGE lithium dodecyl sulphate sample buffer (Invitrogen) and heat denatured for 10 min in a water bath at 80 uC. Fifteen microlitres of each was loaded onto a pre-cast 4-12 % NuPAGE Novex Bistris gel in conjunction with the XCell Sure Lock system (Invitrogen) together with 5 ml pre-stained molecular mass marker (Kaleidoscope Precision Plus Broad Range, Bio-Rad) as was used for the zymogram experiments. After resolving in PAGE, protein bands were transferred to polyvinylidene fluoride membranes (BioRad). The membranes were blocked for 1 h in 3 % BSA (BovoStar, Bovogen) and incubated overnight with 15 ml rabbit polyclonal antiprotease IV antibody (1 : 2000 in blocking solution; kindly supplied by Professor R. O'Callaghan and Dr B. Thibodeaux, Louisiana State University, USA). Unbound primary antibody was removed by three PBS washes. The membranes were then incubated with 15 ml of secondary antibody solution, 1 : 2000 anti-rabbit IgG conjugated to alkaline phosphatase (Sigma-Aldrich) in blocking solution, for 1 h. The targeted bands were visualized after adding 5-bromo-4-chloro-3-indolylphosphate-nitro blue tetrazolium (Roche).
Genetic manipulations and complementation. The lasRI region of the PAO1 genome was amplified by PCR with primers supplied by Dr Scott Beatson (Beatson et al., 2002) using the same conditions as in the amplification of the protease IV gene, except with an annealing temperature of 58 uC. The amplified DNA was blunt-end cloned into the EcoRV restriction enzyme site of P. aeruginosa shuttle vector pUCPSK. The resulting construct, pUCPlasRI, was verified for sequence integrity and orientation by a vector (T7)-and insert (lasRI-r)-specific PCR using conditions as above. The pUCPlasRI plasmid was transformed into competent E. coli DH5a cells. After culturing in TSB containing ampicillin, replicated plasmids were purified using the Aurum Plasmid Mini kit (Bio-Rad). Purified pUCPlasRI (100 ng) was then used to transform chemically competent P. aeruginosa strains PAO1DlasRI : : Gm, Paer1 and Paer3. Transformants were plated onto solid media containing ampicillin and carbenicillin and incubated at 37 uC overnight. A 
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single colony of each complemented P. aeruginosa strain was cultured in TSB containing ampicillin and carbenicillin and then subcultured into TSB containing no antibiotics. Supernatants were prepared and analysed as before by Western blotting and Chromozym PL assay for the presence and activity of the mature protease IV protein.
Pyoverdine production. Pyoverdine concentrations in cell-free bacterial supernatants were determined using the method of Wilderman et al. (2001) . Briefly, OD 660 of overnight cultures was monitored, cell-free culture supernatant was diluted 1 : 10 with PBS, and A 405 was determined using a spectrophotometer. The production of pyoverdine (mM) was normalized by bacterial growth; total protease activity was divided by optical density to result in mM/OD 660 .
Nomenclature. Protease IV has also been referred to in the literature as endoprotease IV and the gene referred to as piv.
RESULTS

DNA sequencing of protease IV genes from clinical isolates
Sequences were made available via the GenBank Database under accession numbers DQ351518-DQ351524. Similarities between protease IV gene sequences ranged from 97.5 to 99.5 %. There were size variations between the PCR products from each isolate, indicating that the regions flanking the coding protease IV region were not genetically identical. The similarity of each strain was calculated relative to all strains and this was displayed as a nearestneighbour phylogenetic tree (Fig. 1) . The strains were divided into two groups in the tree: group A comprising strains PA103-29, 6206, Paer2, Paer17 and Paer26; group B comprising PAO1, 6294, Paer1 and Paer3 (Fig. 1) . DNA sequences of the protease IV genes of the test strains are aligned in Fig. 2 . In comparison with the published gene sequence of PAO1, there were 24 occurrences of nucleotide variations that were conserved in all group A strains. Seven of these variations were within the promoter region and 17 were within the coding sequence. There were seven instances in which strains Paer1, Paer3 and 6294 of group B showed conserved nucleotide variations that differed from sequences of strain PAO1 and the group A strains. The differences occurred within the ORF of the protease IV coding sequence.
When the coding sequences were translated, four conserved amino acid variations occurred at residues 23, 57, 102 and 137 within the signal sequence and pro-peptide (Fig. 3) 
Detection of protease IV in clinical isolates
The activities of protease IV in P. aeruginosa isolates were visualized by gelatin zymography. A gelatinolytic band at an apparent molecular mass of~350 kDa was seen in all samples (Fig. 4) . This band has previously been suggested to be protease IV (Caballero et al., 2001) ; although the enzyme has a molecular mass of 26 kDa, it aggregates under SDS reducing conditions and is resolved at a high molecular mass within the gel (Caballero et al., 2001) . The protease IV band size and intensity were maximal in strain 6294. The bands of protease IV activity in the lowprotease-producing strains Paer1, Paer 2, Paer 3, Paer 17, Paer 26 and 6206 were not as large or dense as those of strains 6294 or PAO1. Pre-treatment of the supernatant with the specific inhibitor TLCK, appeared to inhibit protease IV activity on the zymogram. Other protease bands were either weak or not visible in the low-proteaseproducing strains and the gelatinolytic band in lane 5 (Fig.  4) with an apparent molecular mass of~80 kDa was most likely PASP (Marquart et al., 2005) . Protease IV activities in P. aeruginosa culture supernatants were determined (Table 2 ). In neat bacterial supernatants, only strains 6294 and PAO1 produced detectable amounts of protease IV, at 28.01 and 12.05 mU ml
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/OD 660 , respectively. Protease IV activity in strains Paer1, Paer 2, Paer 3, Paer 17, Paer 26 and 6206 was only detected after ten-fold concentration of supernatants and ranged from 0.10-0.18 mU ml 21 /OD 660 . In all samples pre-treated with TLCK, no protease IV activity was detected, even in the ten-fold concentrated samples. Western blotting was performed to determine the relative level of the protease IV protein in each supernatant. In neat supernatants, only strains 6294 and PAO1 produced a band corresponding to the protease IV standard (results not shown). An extension of the development stage produced a number of additional higher molecular mass bands in samples other than 6294 and PAO1 as seen in previous work by Caballero et al. (2004) . For ten-fold concentrated supernatants, a band of the same molecular mass as the protease IV control (25 kDa) was seen in all strains (Fig. 5) . In addition, a band at an apparent molecular mass of 23 kDa was seen in all concentrated samples. (Caballero et al., 2004) . Highlighted bases represent nucleotide variations leading to changes in amino acid residues. Hyphens indicate nucleotides not determined. Fig. 3 . Translated protein coding sequences of the protease IV genes of the test strains and strain PA103-29, aligned to reference strain PAO1. Full stops represent amino acid residues matching those of strain PAO1. Amino-acid variations from the protein sequence of strain PAO1 are indicated with the appropriate letter. Underlined sequences represent putative transmembrane domains (Caballero et al., 2004) . Highlighted residues represent catalytic triad (Traidej et al., 2003) . Asterisks represent stop codons.
T. C. R. Conibear and others
Complementation of lasRI-deficient isogenic mutant and clinical isolates
The quorum-sensing mutant PAO1DlasRI : : Gm and the previously reported lasRI-deficient clinical isolates Paer1 and Paer3 exhibited little or no protease IV production when examined via chromogenic substrate assay and Western blotting. These strains were successfully complemented with pUCPlasRI to form PAO1DlasRI+lasRI, Paer1+lasRI and Paer3+lasRI, as indicated by the restoration of LasB elastase activity (data not shown). The use of the chromogenic substrate indicated protease IV production was restored in the complemented lasRI mutant PAO1DlasRI and clinical isolates of Paer1 and Paer3 to similar levels to that exhibited by wild-type strain PAO1 (Fig. 6a) . Immunoblot analysis of culture supernatants also confirmed that protease IV protein production in these strains was increased to levels similar to that of wild-type strain PAO1 (Fig. 6b) .
Pyoverdine concentrations in cell-free supernatants
Pyoverdine concentrations in cell-free supernatants of wildtype strains PAO1 and 6294 were 2421 and 2273 mM/OD 660 , respectively. Pyoverdine production levels in 'low-protease'-producing strains Paer1, Paer2, Paer3, Paer17, Paer26, 6206 and PAO1DlasRI : : Gm were all below 1050 mM/OD 660 and were between 30 and 43 % of the concentration produced by strain PAO1. In complemented strains Paer1+lasRI, Paer3+lasRI and PAO1DlasRI+lasRI, levels of pyoverdine production were restored to ¢98 % of that produced by PAO1 (Table 3) .
DISCUSSION
Protease IV gene sequences were characterized in seven P. aeruginosa isolates. This work extends that of Caballero et al. (2004) who compared the protease IV sequence of strain PA103-29 to that of PAO1. Up to 2.5 % (43/1706 nt) nucleotide variation was observed between all strains in the current study. Caballero et al. (2004) previously reported the coding sequence of protease IV genes in strains PAO1 and PAO103-29 exhibiting only 1.5 % variation (26/ 1706 nt). This is the first time, to our knowledge, that multiple sequences for whole protease IV virulence genes have been determined and further demonstrates that protease IV genes of both virulent and avirulent P. aeruginosa strains show negligible DNA variation. However, following DNA sequence alignment, it was possible to distinguish two divergent phylogenetic groups: group A, containing strains PAO103-29, Paer2, Paer17, Paer26 and 6206; and group B, containing strains PAO1, Paer1, Paer3 and 6294. It is of interest that these similarities correlate with the presence of the genes that confer an invasive or cytotoxic phenotype (Fleiszig et al., 1996 (Fleiszig et al., , 1997 Zhu et al., 2006) . Strains containing exoU (group A) or exoS (group B) were found to be most similar with regards to their piv gene sequences. Strain Paer17 was the only exception to these findings, containing exoS but grouping in group A (with the exoU-containing isolates) based on piv gene sequence similarity data.
There were a number of conserved gene mutations leading to amino acid substitution in the protein sequence, Table 2 . Protease IV activity in cell-free supernatants of strains of P. aeruginosa
The supernatant of each P. aeruginosa strain was allowed to react with the specific protease IV substrate Chromozym PL to determine the number of enzyme units ml however there was no correlation between any of these mutations and a low-protease-producing phenotype. There were no amino acid changes that consistently created or removed potential auto-cleavage sites (lysine residues), premature stop codons or alterations to the catalytic triad (Traidej et al., 2003) . The conserved amino acid changes detected in our clinical isolates agreed with those detected by Caballero et al. (2004) while the non-conserved amino acid substitutions are reported here for the first time, to our knowledge. These results indicate that the potential to secrete protease IV may be determined by upregulation of protease IV gene expression rather than variations in gene structure causing a structurally altered protein. The role and function of the non-conserved amino acid substitutions are not known and warrant further investigation.
Within the isolates examined, Paer2, Paer17, Paer26 and 6206, despite being low-protease-producing strains, were virulent in a murine scratch keratitis model (Zhu et al., 2004) . Of these strains, Paer17 is the only exoS-containing isolate in group A; it causes microbial keratitis (MK) and is a low-protease-producing strain. All other MK isolates in the present study either possess exoU or are high protease producers, an observation consistent with the findings of others (Winstanley et al., 2005) . Thus, it is of interest that strain Paer17 is more similar to exoU-containing isolates in phylogenetic analysis of piv gene sequences. Lee et al. (2006) have reported pathogenicity-related genes, the presence or absence of which do not correlate directly with degree of virulence, suggesting virulence is more complex than simple autonomous functioning of virulence genes. Strain-variable virulence-associated genes have been reported within genomic islands of P. aeruginosa (Battle et al., 2009) . These mobile genetic elements can contribute to virulence in a combinatorial manner with other accessory genome 'modules', resulting in strain-specific virulence (Lee et al., 2006) . There are 45 specific genome modules that tend to be associated in MK strains (Stewart et al., 2011) . The similarity of the piv gene sequence of strain Pear17 to those of strains possessing the exoU gene rather than the exoS gene, corresponding to increased virulence of this low-protease-containing strain, suggests that the piv gene might be part of a genomic island containing other virulence factors that combine with genome modules within this strain to increase virulence. Singh et al. (2010) recently suggested a reciprocal regulation of the TTSS and Pseudomonas Quinolone Signal (PQS), both regulated by the las and rhl quorum-sensing systems (Bleves et al., 2005) . Furthermore, host defences can disrupt quorum sensing of invading P. aeruginosa (Chun et al., 2004) , suggesting a complex interplay of virulence factors and an orchestration of host and pathogen responses during infection, all of which requires further elucidation.
From our previous studies it has been found that all the lowprotease-producing strains used in this study (Paer1, Paer2, Paer3, Paer17, Paer26 and 6206) also produced low extracellular concentrations of N-acylhomoserine lactones (AHLs), suggesting the quorum-sensing circuits in these isolates are not fully active (Zhu et al., 2002) . These isolates had no detectable elastase activity in vitro, a virulence factor that is directly regulated by the las quorum-sensing system. Paer1 and Paer3 were found to be deficient in the lasRI gene, and Paer2 was deficient in the rhlR and rhlAB genes (Zhu et al., 2004) . We also confirmed that PAO1DlasRI had decreased protease IV production. By replacing the defective lasRI genes, we demonstrated that protease IV secretion can be restored to the normal levels. Restoration of protease IV secretion was also observed in clinical isolates that were known to be defective in lasRI genes (Paer1 and Paer3), suggesting that protease IV production is also controlled, at least in part, through quorum-sensing regulation; these findings are in agreement with the work of Arevalo-Ferro et al. (2003) . However, control may not be direct as there is no evidence of a lux box (Bleves et al., 2005) within any of the gene sequences. Traidej et al. (2003) suggested that protease IV can utilize the type II secretion pathway to travel to the cell exterior. The las quorum-sensing system directly controls the expression of the type II xcp gene cluster, producing channels that allow direct transportation of proteins to the cell exterior (Chapon-Hervé et al., 1997) . When the las quorum-sensing system is disrupted, it is likely that protease IV, and other virulence-associated proteins are unable to be effectively transported and activated.
Protease IV production is influenced by the availability of iron in the P. aeruginosa culture, which also controls the alternative sigma factor PvdS (Wilderman et al., 2001) . PvdS regulates expression of genes required for pyoverdine production, and is therefore upregulated when P. aeruginosa is in an iron-deficient environment. Pyoverdine upregulates production of itself as well as protease IV (Lamont et al., 2002) and its synthesis is also controlled by lasRI (Stintzi et al., 1998 ). In the current study, the lowprotease-producing isolates also demonstrated low pyoverdine production. In each of the genetically restored quorum-sensing mutants, PAO1DlasRI, Paer1 and Paer3, the increase in protease IV secretion to normal levels correlated with an increase in pyoverdine production, confirming both pyoverdine and protease IV productions are under control of the lasRI gene. The direct influence of pyoverdine on the production of protease IV warrants further investigation.
In summary, we have identified that all the ocular isolates tested have a functional protease IV gene, which is highly conserved yet can be classified into two distinct phylogenetic groups. The expression and secretion of protease IV in clinical isolates was determined to be under the control of the las quorum-sensing system, a global regulator of pathogenesis. Further in vivo analysis of pathogenic clinical isolates is needed to elucidate the complex interrelationship between quorum sensing, TTSS and protease IV production of P. aeruginosa. 
